Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

Their approach isn’t about cloning but rewriting DNA to create a mammoth hybrid—a mix of the modern Asian elephant and woolly mammoth traits. Think of it as bringing back the mammoth’s ...

The woolly mammoth, a giant that roamed the icy expanses of the planet during the Pleistocene epoch, became extinct around 4,000 years ago and is at the center of Colossal’s mission. It’s a ...

Bones of a 13,500-year-old woolly mammoth were uncovered during a dig 36 years after they were discovered under the garage of ...

No, this isn’t a new Jurassic Park plot: A real-life woolly mammoth could be on Earth by the decade’s end. Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in ...

GUAC is Manuel’s response to his overwhelming grief, his love for his son, and his call to be an activist fighting for gun ...

If your ski trips only involve downhill skiing, you're missing out. Here's out to get the most out of your winter trip to ...

The goal to revive the woolly mammoth by 2027 is a huge one, and the company has put much stock into how it plans to bring these extinct creatures back to life – as well as why it wants to do that.

If you thought Jurassic Park was "just a movie," the concept of bringing pre-historic animals back to life is being worked ... mission to bring back the woolly mammoth, dodo and thylacine (also ...